Back to results
US 2024/0254076 A1Published application
Lipid nanomaterials and uses thereof
AssigneeOhio State Innovation Foundation
InventorsYizhou DONG, Chang WANG, Yuebao ZHANG, Yonger XUE
Life of this patent
Estimating the term…
Abstract
Disclosed herein are lipid formulations that can be used in drug delivery and screening.
Claims52
A compound represented by any one of Formulas I through XIX, or a pharmaceutically acceptable salt thereof:
- wherein
- R1, R2, R3, and R4 are each independently a substituted or unsubstituted C1-C20 alkyl;
- R5 and R14 are each independently hydrogen, a substituted or unsubstituted C1-C5 alkyl;
- R6, R7, R8, R9, R10, R11, R12, and R13 are each independently hydrogen, OH, halogen, or substituted or unsubstituted C1-C5 alkyl;
- R15, R16, and R17 are each independently hydrogen, OH, halogen, or substituted or unsubstituted C1-C5 alkyl;
- and
- R18 is OH or substituted or unsubstituted C1-C10 alkyl.
4 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.